Smoking and cardiovascular health: A review of the epidemiology, pathogenesis, prevention and control of tobacco

Indian Journal of Medical Sciences

Volumn 63, Issue 11, 2009, Pages 520-533

  Prasad, D S ^a   Kabir, Zubair ^b   Dash, A K ^c   Das, B C ^d  

^a Sudhir Heart Centre   (India)

^b Research Institute for a Tobacco Free Society   (Ireland)

^c MKCG MEDICAL COLLEGE   (India)

^d KIIT UNIVERSITY   (India)

Author keywords

Cardiovascular disease; Risk factor; Smoking

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COCHRANE LIBRARY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY ARTERY THROMBOSIS; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; EMBASE; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPERTENSION; INDIA; MEDLINE; MORBIDITY; MORTALITY; OXYGEN TRANSPORT; PATHOGENESIS; PATHOPHYSIOLOGY; PUBLIC HEALTH; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION;

CARDIOVASCULAR DISEASES; HEALTH PROMOTION; HEALTH STATUS; HUMANS; IRELAND; PREVALENCE; RISK FACTORS; SMOKING; SMOKING CESSATION; SOCIAL MARKETING; TOBACCO SMOKE POLLUTION;

EID: 76549088548     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.58884     Document Type: Review

References (96)

1. Murray CJ, Lopez AD. Mortality By Cause For Eight Regions Of The World: Global Burden Of Disease Study. Lancet 1997;349:1269-1276
2. Ockene IS, Miller NH. Cigarette Smoking, Cardiovascular Disease, And Stroke: A Statement For Healthcare Professionals From The American Heart Association. Circulation 1997;96:3243-3247
3. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk Factors For Congestive Heart Failure In US Men And Women: NHANES I Epidemiologic Follow-Up Study Arch Intern Med 2001;161:996-1002.
4. Muscat JE, Harris RE, Haley NJ, Wynder EL. Cigarette Smoking And Plasma Cholesterol. Am Heart J 1991;121:141-147
5. Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette Smoking Acutely Increases Platelet Thrombus Formation In Patients With Coronary Artery Disease Taking Aspirin. Circulation 1995;92:2432-2436
6. Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects Of Long- Term Smoking On Myocardial Blood Flow, Coronary Vasomotion,And Vasodilator Capacity. Circulation 1998;98:119-125
7. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet Spontaneous Aggregation In Platelet- Rich Plasma Is Increased In Habitual Smokers. Thromb Res1999;93:271-278
8. Jha P, Chaloupka Frank J. Curbing The Epidemic. Governments And The Economics Of Tobacco Control. Washington, DC: World Bank; 1999.
9. Ockene JK. Smoking Intervention: A Behavioral, Educational And Pharmacological Perspective. In: Ockene IS, Ockene JK, Editors. Prevention Of Coronary Heart Disease. Boston. Littlebrown; 1992. P. 201-230
10. Singh V, Gupta R. Prevalence Of Tobacco Use And Awareness Of Risks Among School Children In Jaipur. J Assoc Physicians India 2006;54:609-612
11. Bartecchi CE, Mackenzie TD, Schrier RW. The Human Costs Of Tobacco Use. N Engl J Med 1994;330:907-912
12. Barnoya J, Glantz SA. Smoking, Secondhand Smoke, And Cardiovascular Disease. In: Willerson JT, Cohn JN, Wellens HJ, Holmes DR, Editors. Cardiovascular Medicine. 3rd Ed. London: Springer-Verlag; 2007. P. 2649-2664
13. Niaura R, Goldstein MG. Smoking. In: Eric J.Topol EJ, Editor. Text Book Of Cardiovascular Medicine CD. 2nd Ed. Cleveland, Ohio: Lippincott Williamsandwilkins; 2002.
14. Wald NJ, Hackshaw AK. Cigarette Smoking: An Epidemiological Overview. Br Med Bull 1996;52:3-11.
15. Edwards R. The Problem Of Tobacco Smoking. BMJ 2004;328:217-219
16. World Health Organization. The World Health Report 2002.Reducing Risks,Promoting Healthy Life. Geneva: WHO; 2002.
17. Tobacco Control: Country Profiles. Atlanta, GA: American Cancer Society; 2000.
18. Report On Tobacco Control In India. New Delhi: Ministry Of Health And Family Welfare, Govt. Of India; Centers For Disease Control And Prevention. USA: World Health Organization; 2004.
19. Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, et al. A Nationally Representative Case-Control Study Of Smoking And Death In India. N Engl J Med 2008;358:1137-1147
20. Rastogi T, Jha P, Reddy KS, Prabhakaran D, Spiegelman D, Stampfer MJ, et al. Bidi And Cigarette Smoking And Risk Of Acute Myocardial Infarction Among Males In Urban India. Tob Control 2005;14:356-358
21. Kabir Z, Clancy L, Connolly GN. Tobacco Control Efforts: Where Is India Now? The Lancet 2007;370:134.
22. Gupta R, Gupta VP, Sarna M, Prakash H, Rastogi S, Gupta KD. Serial Epidemiological Surveys In An Urban Indian Population Demonstrate Increasing Coronary Risk Factors Among The Lower Socioeconomic Strata. J Assoc Physicians India 2003;51:470-477
23. Crofton J, Bjartveit K. Smoking As A Risk Factor For Chronic Airways Disease. Chest 1989;96:307S-12S. (Pubitemid 19223870)
24. Boyle P. Cancer, Cigarette Smoking And Premature Death In Europe: A Review Including The Recommendations Of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 1997;17:1-60.
25. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic Effects Of Smoking. Chest 2007;131:1557-1566
26. Repace J. Tobacco Smoke Pollution. In: Orleans CT, Slade J, Editors. Nicotine Addiction: Principles And Management. New York: Oxford University Press; 1993.
27. Aronow WS. Effect Of Passive Smoking On Angina Pectoris. N Engl J Med 1978;299:21-24
28. Glantz SA, Parmley WW. Passive Smoking And Heart Disease: Epidemiology, Physiology, And Biochemistry. Circulation 1991;83:1-12.
29. Barnoya J, Glantz SA. Cardiovascular Effects Of Secondhand Smoke: Nearly As Large As Smoking. Circulation 2005;111:2684-2698
30. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, et al. Brief Secondhand Smoke Exposure Depresses Endothelial Progenitor Cells Activity And Endothelial Function. J Am Coll Cardiol 2008;51:1760-1771
31. Flouris AD, Vardavas CI, Metsios GS, Tsatsakis AM, Koutedakis Y. Biological Evidence For The Acute Health Effects Of Secondhand Smoke Exposure. Am J Physiol Lung Cell Mol Physiol 2009;00215.[Epub Ahead Of Print]
32. National Cancer Institute. Health Effects Of Exposure To Environmental Tobacco Smoke: The Report Of The California Environmental Protection Agency, Smoking And Tobacco Control Monograph No. 10. NIH Pub. No. 99-4645. Bethesda, MD: Department Of Health And Human Services, National Institutes Of Health, National Cancer Institute, 1999.
33. U.S. Department Of Health And Human Services. The Health Consequences Of Smoking. A Report Of The Surgeon General. Atlanta: Centers For Disease Control And Prevention, National Center For Chronic Disease Prevention And Health Promotion, Office On Smoking And Health, 2004.
34. Lightwood JM, Glantz SA. Short-Term Economic And Health Benefits Of Smoking Cessation: Myocardial Infarction And Stroke. Circulation 1997;96:1089-1096
35. U.S. Department Of Health And Human Services. The Health Benefits Of Smoking Cessation: A Report Of The Surgeon General, DHHS Publication No. (CDC) 90-8416. Rockville, MD: U.S. Department Of Health And Human Services, Public Health Service, Centers For Disease Control And Prevention, 1990.
36. Mackay J, Mensah GA. The Atlas Of Heart Disease And Stroke. Geneva: World Health Organization; Centres For Disease Control And Prevention; 2004.
37. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative And Absolute Excess Risks Of Coronary Heart Disease Among Women Who Smoke Cigarettes. N Engl J Med 1987;317:1303-1309
38. Benowitz NL. Cigarette Smoking And Cardiovascular Disease: Pathophysiology And Implications For Treatment. Prog Cardiovasc Dis 2003;46:91-111.
39. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect Of Preoperative Smoking Intervention On Postoperative Complications:A Randomised Clinical Trial. Lancet 2002;359:114-117
40. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect Of Potentially Modifiable Risk Factors Associated With Myocardial Infarction In 52 Countries (The INTERHEART Study): Case- Control Study. Lancet 2004;364:937-952 (Pubitemid 39208455)
41. Mähönen MS, Mcelduff P, Dobson AJ, Kuulasmaa KA, Evans A; WHO MONICA Project. Current Smoking And The Risk Of Nonfatal Myocardial Infarction In The WHO MONICA Project Populations. Tob Control 2004;13:244-250.
42. Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K, et al. Cigarette Smoking, Tar Yields, And Non-Fatal Myocardial Infarction: 14,000 Cases And 32,000 Controls In The United Kingdom. The International Studies Of Infarct Survival (ISIS) Collaborators. BMJ 1995;311:471-477
43. Quek DK, Lim LY, Ong SB. Cigarette Smoking And The Risk Of Myocardial Infarction,And Acute Non-Infarct Coronary Events Among Malaysian Women. Med J Malaysia 1989;44:210-223
44. Gramenzi A, Gentile A, Fasoli M, D'Avanzo B, Negri E, Parazzini F, et al. Smoking And Myocardial Infarction In Women: A Case- Control Study From Northern Italy. J Epidemiol Community Health 1989;43:214-217
45. Kawachi I, Colditz GA, Speizer FE, Manson JE, Stampfer MJ, Willett WC, et al. A Prospective Study Of Passive Smoking And Coronary Heart Disease. Circulation 1997;95:2374-2379
46. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive Smoking And The Risk Of Coronary Heart Disease -- A Meta- Analysis Of Epidemiologic Studies. N Engl J Med 1999;340:920-926
47. Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, et al. Risk Factors For Acute Myocardial Infarction In Indians: A Caseñcontrol Study. Lancet 1996;348:358-363
48. Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, et al. A Nationally Representative Case-Control Study Of Smoking And Death In India. N Engl J Med 2008;358:1137-1147
49. Sargent RP, Shepard RM, Glantz SA. Reduced Incidence Of Admissions For Myocardial Infarction Associated With Public Smoking Ban: Before And After Study. BMJ 2004;328:977-983
50. Kabir Z, Connolly GN, Clancy L, Koh HK, Capewell S. Coronary Heart Disease Deaths And Decreased Smoking Prevalence In Massachusetts,1993-2003. Am J Public Health 2008;98:1468-1469
51. Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, Mclean BK, Peragallo-Dittko V, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis 2003;14:335-348
52. Benowitz NL. Cigarette Smoking And Cardiovascular Disease:Pathophysiology And Implications For Treatment: 1. Prog Cardiovasc Dis 2003;46:91-111.
53. Hecht SS. Tobacco Smoke Carcinogens And Lung Cancer. J Natl Cancer Inst 1999;91:1194-1210
54. Hoffmann D, Hoffmann I, El-Bayoumy K. The Less Harmful Cigarette: A Controversial Issue. A Tribute To Ernst L. Wynder. Chem Res Toxicol 2001;14:767-790
55. Ambrose JA, Barua RS. The Pathophysiology Of Cigarette Smoking And Cardiovascular Disease: An Update. J Am Coll Cardiol 2004;43:1731-1737
56. Sun YP, Zhu BQ, Browne AE, Sievers RE, Bekker JM, Chaterjee K, et al. Nicotine Does Not Influence Arterial Lipid Deposits In Rabbits Exposed To Second-Hand Smoke. Circulation 2001;104: 810-814
57. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. Air Pollution And Cardiovascular Disease: A Statement For Healthcare Professionals From The Expert Panel On Population And Prevention Science Of The American Heart Association. Circulation 2004;109:2655-2671
58. Moffatt RJ, Stamford BA, Biggerstaff KD. Influence Of Worksite Environmental Tobacco Smoke On Serum Lipoprotein Profiles Of Female Nonsmokers. Metabolism 1995;44:1536-1539
59. Moffatt RJ, Chelland SA, Pecott DL, Stamford BA. Acute Exposure To Environmental Tobacco Smoke Reduces HDL-C And HDL2-C. Prev Med 2004;38:637-641
60. Valkonen M, Kuusi T. Passive Smoking Induces Atherogenic Changes In Low-Density Lipoprotein. Circulation 1998;97:2012-2016
61. Griendling KK, Fitzgerald GA. Oxidative Stress And Cardiovascular Injury: Part I: Basic Mechanisms And In Vivo Monitoring Of ROS. Circulation 2003;108:1912-1916
62. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase In Circulating Products Of Lipid Peroxidation (F2-Isoprostanes) In Smokers -- Smoking As A Cause Of Oxidative Damage. N Engl J Med 1995;332:1198-1203
63. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship Between Cigarette Smoking And Novel Risk Factors For Cardiovascular Disease In The United States. Ann Intern Med 2003;138:891-897
64. Howard G, Wagenknecht LE, Burke GL, Diez- Roux A, Evans GW, Mcgovern P, et al. Cigarette Smoking And Progression Of Atherosclerosis: The Atherosclerosis Risk In Communities (ARIC) Study. JAMA 1998;279:119-124
65. Smith FB, Lowe GD, Lee AJ, Rumley A, Leng GC, Fowkes FG. Smoking, Hemorheologic Factors, And Progression Of Peripheral Arterial Disease In Patients With Claudication. J Vasc Surg 1998;28:129-135
66. Law MR, Morris JK, Wald NJ. Environmental Tobacco Smoke Exposure And Ischaemic Heart Disease: An Evaluation Of The Evidence. BMJ 1997;315:973-980
67. Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T. Long-Term Smoking Impairs Platelet-Derived Nitric Oxide Release. Circulation 1996;94:3109-3114
68. Newby DE, Mcleod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, et al. Impaired Coronary Tissue Plasminogen Activator Release Is Associated With Coronary Atherosclerosis And Cigarette Smoking: Direct Link Between Endothelial Dysfunction And Atherothrombosis. Circulation 2001;103:1936-1941
69. Zidovetzki R, Chen P, Fisher M, Hofman FM, Faraci FM. Nicotine Increases Plasminogen Activator Inhibitor-1 Production By Human Brain Endothelial Cells Via Protein Kinase Cûassociated Pathway. Stroke 1999;30:651-655 (Pubitemid 29115406)
70. Pope CA 3rd, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, et al. Acute Exposure To Environmental Tobacco Smoke And Heart Rate Variability. Environ Health Perspect 2001;109:711-716
71. Stein PK, Rottman JN, Kleiger RE. Effect Of 21 Mg Transdermal Nicotine Patches And Smoking Cessation On Heart Rate Variability. Am J Cardiol 1996;77:701-705
72. Yotsukura M, Koide Y, Fujii K, Tomono Y, Katayama A, Ando H, et al. Heart Rate Variability During The First Month Of Smoking Cessation. Am Heart J 1998;135:1004-1009
73. Gvozdjakova A, Kucharska J, Gvozdjak J. Effect Of Smoking On The Oxidative Processes Of Cardiomyocytes. Cardiology 1992;1992:81-84
74. Gvozdjak J, Gvozdjakova A, Kucharska J, Bada V. The Effect Of Smoking On Myocardial Metabolism. Czech Med 1987;10:47-53.
75. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, et al. Cigarette Smoke Exposure And Hypercholesterolemia Increase Mitochondrial Damage In Cardiovascular Tissues. Circulation 2002;105:849-854
76. Mahmud A, Feely J. Effect Of Smoking On Arterial Stiffness And Pulse Pressure Amplification. Hypertension 2003;41:183-187
77. Mahmud A, Feely J. Effects Of Passive Smoking On Blood Pressure And Aortic Pressure Waveform In Healthy Young Adults- Influence Of Gender. Br J Clin Pharmacol 2004;57:37-43.
78. Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable Effect Of Smoking On The Elastic Properties Of The Human Aorta. Circulation 1997;95:31-38
79. Stefanadis C, Vlachopoulos C, Tsiamis E, Diamantopoulos L, Toutouzas K, Giatrakos N, et al. Unfavorable Effects Of Passive Smoking On Aortic Function In Men. Ann Intern Med 1998;128:426-434
80. Isselbacher EM. Thoracic And Abdominal Aortic Aneurysms. Circulation 2005;111:816-828
81. Mcvary KT, Carrier S, Wessells H; Subcommittee On Smoking And Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society Of North America. Smoking And Erectile Dysfunction: Evidence Based Analysis. J Urol 2001;166:1624-1632
82. Lightwood J, Fleischmann KE, Glantz SA. Smoking Cessation In Heart Failure: It Is Never Too Late. J Am Coll Cardiol 2001;37:1683-1684
83. Critchley JA, Capewell S. Mortality Risk Reduction Associated With Smoking Cessation In Patients With Coronary Heart Disease: A Systematic Review. JAMA 2003;290:86-97.
84. Suskin N, Sheth T, Negassa A, Yusuf S. Relationship Of Current And Past Smoking To Mortality And Morbidity In Patients With Left Ventricular Dysfunction: 1. J Am Coll Cardiol 2001;37:1677-1682
85. Effect Of Metoprolol CR/XL In Chronic Heart Failure: Metoprolol CR/XL Randomised Intervention Trial In Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
86. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The Effect Of Spironolactone On Morbidity And Mortality In Patients With Severe Heart Failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717
87. Effect Of Enalapril On Survival In Patients With Reduced Left Ventricular Ejection Fractions And Congestive Heart Failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
88. Fiore MC, Bailey W, Cohen S, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating Tobacco Use And Dependance. Clinical Practice Guideline. Rockville, MD: U.S. Department Of Health And Human Services. Public Health Services. 2000.
89. Ockene J, Kristeller JL, Goldberg R, Ockene I, Merriam P, Barrett S, et al. Smoking Cessation And Severity Of Disease: The Coronary Artery Smoking Intervention Study. Health Psychol 1992;11:119-126
90. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, et al. Cardiac Rehabilitation: Clinical Practice Guideline No. 17. Rockville, MD: Agency For Health Care Policy And Research And The National Heart, Lung, And Blood Institute, Public Health Service, U.S. Department Of Health And Human Services. 1995.
91. Ockene JK, Aney J, Goldberg RJ, Klar JM, Williams JW. A Survey Of Massachusetts Physicians' Smoking Intervention Practices. Am J Prev Med 1988;4:14-20.
92. Anda RF, Remington PL, Sienko DG, Davis RM. Are Physicians Advising Smokers To Quit? The Patient's Perspective. JAMA 1987;257:1916-1919
93. Ayanian JZ, Cleary PD. Perceived Risks Of Heart Disease And Cancer Among Cigarette Smokers. JAMA 1999;281:1019-1021
94. Weinstein ND, Marcus SE, Moser RP. Smoker's Unrealistic Optimism About Their Risk. Tob Control 2005;14:55-59
95. Barnoya J, Glantz SA. Smoking. In: Topol EJ, Editor. Textbook Of Cardiovascular Medicine. 3rd Ed. New Delhi: Wolters Kluwer (India); 2007. P. 109-120
96. Prasad DS, Das BC. Physical Inactivity: A Cardiovascular Risk Factor. Indian J Med Sci 2009;63:33-42.